OHSU Innovates 2021 Impact Report highlights many of the successes and positive impacts over the past year
OHSU expedites promising new technologies to tackle COVID-19
2021 Biomedical Innovation Program awards announced
Latest news
OHSU startup ProMedix selected to participate in mHUB Accelerator program for medical devices
November 10
AstraZeneca accepts six new research projects from Knight Cancer Institute
October 29
OHSU Startup Luciole Pharmaceuticals announces collaboration
October 6
OHSU startup awarded $4.3M in grants for cancer research
September 21
OHSU awarded $3.8 million NIH grant to launch oral health research training program
September 2, 2021
We welcome and appreciate the collaborative nature of organizations that want to be a part of the ongoing innovative and entrepreneurial efforts at OHSU. Thank you to our sponsors!
Featured technology
Nanoparticle ultrasound contrast agents
Technology #2823
Adem Yildirim Ph.D. and colleagues at the Knight Cancer Institute Cancer Early Detection Advanced Research (CEDAR) center have developed novel nanoparticle contrast agents, that are small enough to accumulate within tumors. These nanoparticle contrast agents can potentially be used with ultrasound for diagnostic and therapeutic applications to improve tumor detection and cancer patient care.
Upcoming events
OHSU Technology Transfer Virtual Office Hours
Every Friday from 9-10 am PST (see O2 calendar for Webex link)
Virtual Lunch & Learn: Utilizing Value Assessments to Determine Clinical & Cost Effectiveness
December 1
Bio in the Valley 2021
December 2
NCATS at 10: Improving Health for All Through Translational Science
December 7
Accelerate Biotech + Digital Health Virtual Happy Hour
December 9
Join our mailing list
Subscribe to the OHSU Innovation and Commercialization mailing list to receive news, events and updates involving OHSU innovations.